
|Videos|March 15, 2016
To What Extent Should People Have Access to Naloxone?
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, outlines his pros and cons for expanded access to naloxone.
Advertisement
Jeffrey Fudin, PharmD, DAAPM, FCCP, FASHP, outlines his pros and cons for expanded access to naloxone.
This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
3
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
4
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
5





































































































